A Comparative Study of Production of [68Ga]PSMA-11 with or without Cassette Type Modules |
Hyun-Sik, Park
(Department of Nuclear Medicine, Seoul National University Bundang Hospital)
Byeong-Min, Jo (BIK THERAPEUTICS Inc.) Hyun-Ho, An (Department of Nuclear Medicine, Seoul National University Bundang Hospital) Hong-Jin, Lee (Department of Nuclear Medicine, Seoul National University Bundang Hospital) Jin-Hyeong, Lee (Department of Nuclear Medicine, Seoul National University Bundang Hospital) Gyeong-Jae, Lee (Department of Nuclear Medicine, Seoul National University Bundang Hospital) Byung-Chul, Lee (Department of Nuclear Medicine, Seoul National University Bundang Hospital) Won-Woo, Lee (Department of Nuclear Medicine, Seoul National University Bundang Hospital) |
1 | Park HS, Lee HJ, An HH, Moon BS, Lee BC, Lee WW, et al. Fully automated radiosynthesis of [68Ga]edotreotide ([68Ga]DOTA-TOC) and its quality controls. J Radiopharm Mol Prob 2017;3(2):85-90 DOI |
2 | Michael M, Yury S, Elisabath E. Gallium-68: Radiolabeling of Radiopharmaceuticals for PET Imaging - A Lot to Consier. Intechopen Web site. Available at: http://www.intechopen.com/chapters/70578. Published December 23, 2019. |
3 | Ukihide T. Prostate-specific membrane antigen(PSMA)- ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer. Japanese Journal of Clinical Oncology, 2020;50(4):349-356 DOI |
4 | Wolfgang PF, Jeremie C, Matthias E, Robert RF, Ashley M, Felix YF, et al. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019;5(6):856-863 DOI |
5 | Michael SH, Nathan L, Roslyn JF, Colin T, Ian V, Paul T, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 2020;395:1208-16 DOI |